• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Hemostatic mechanism of Jianpi Yiqi Shexue decoction(健脾益气摄血方)in treatment of immune thrombocytopenia

摘要OBJECTIVE:To explore the early hemostatic mechanism of Jianpi Yiqi Shexue decoction(健脾益气摄血方,JYSD)in treating immune thrombocytopathy(ITP),based on the functional homeostasis of brain-intestine axis and blood neurotransmitterMETHODS:Non-drug treatment cases:Healthy volunteers were selected as normal control group and compared with patients with dysfunctional uterine bleeding,gastrointestinal tumors with bleeding and ITP,to detect the changes of blood 5-hydroxytryptamine(5-HT),β-endorphin(β-EP),vasoactive intestinal peptide(VIP)and compare the changes of blood neuro-transmitters in patients with different disease symptoms.Drug treatment cases:According to the randomized controlled multicenter clinical trial,272 ITP patients were randomly divided into three groups:treatment group(JYSD)combined group(JYSD+Prednisone)control group(Prednisone).The changes of blood neuro-transmitter(5-HT,β-EP,VIP)before and after treatment were detected on the basis of peripheral blood platelet(PLT)and grade score.RESULTS:Non-drug treatment cases:compared with the normal control group,the 5-HT level was higher,and the VIP and β-EP levels were both lower in the ITP group(P<0.001),and the 5-HT,VIP and β-EP levels in the Gastrointestinal tumors with bleeding group were also lower compared with the normal control group(P<0.05,0.001).Drug treatment cases:The PLT grading scores of the combination group and the control group after treatment were lower than that before treatment(P<0.05,0.001).The PLT grading score of the 3 groups were compared in pairs after treatment:the combination group was the lowest among the 3 groups,which was better than the treatment group,but no better than the control group(vs the treatment group,P=0.005,vs the control group,P=0.709).The statistical results of full analysis set(FAS)and per protocol set(PPS)were consistent.The bleeding symptom scores of the treatment and combination groups began to drop 7 d after treatment,and kept dropping 14 d after treatment until the end of the study(P<0.05).On the other hand,the control group started to show favorable results 14 d after treatment(P<0.05).The FAS and PPS analysis results were consistent.In the control group,the 5-HT level was higher and VIP level was lower after treatment,compared with those before treatment(P<0.05,0.001).The β-EP levels were both increased in the treatment and combination group after treatment,compared with those before treatment(P<0.05).After treatment,the β-EP levels in the treatment and control groups were significantly lower compared with the combination groups(P<0.05).After treatment,compared with the control group,the VIP levels in the treatment and combination groups were up-regulated,and the differences were statistically significant by rank sum test(P<0.01),and by t-test(P=0.0002,0.0001).CONCLUSIONS:The prednisone tablet is better than the JYSD in increasing the level of PLT,while prednisone tablet combined with JYSD has more advantages in improving patients'peripheral blood PLT levels.However,in improving the bleeding time of ITP patients,the combination of the two drugs was significantly delayed compared with the single usage,showing the characteristics and advantages of traditional Chinese medicine.JYSD can regulate the neurotransmitter level of ITP patients through the function of the brain-gut axis,mobilize 5-HT in the blood of ITP patients to promote the contraction of blood vessels and smooth muscles,and activate the coagulation mechanism are the early hemostatic mechanisms of JYSD.Up-regulate the levels of β-EP and balancing VIP levels may be an important part of the immune mechanism of JYSD for regulating ITP patients.

更多
广告
作者 LI Ruibai [1] CHEN Ke [2] MA Wei [3] ZHANG Yayue [3] HOU Li [3] CHEN Xinyi [3] 学术成果认领
作者单位 Department of Oncology and Hemotology,Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,China;Department of Hemotology,Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing 100091,China [1] Department of Hemotology,Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing 100091,China [2] Department of Oncology and Hemotology,Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,China [3]
栏目名称 Original Articles
DOI 10.19852/j.cnki.jtcm.20240423.003
发布时间 2024-07-12
提交
  • 浏览4
  • 下载0
中医杂志(英文版)

中医杂志(英文版)

2024年44卷3期

537-544页

SCIMEDLINECSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷